These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35150456)

  • 1. Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19.
    Sadlier C; Albrich WC; Neogi U; Lunjani N; Horgan M; O'Toole PW; O'Mahony L
    Allergy; 2022 May; 77(5):1623-1625. PubMed ID: 35150456
    [No Abstract]   [Full Text] [Related]  

  • 2. Focusing on Asthma and Chronic Obstructive Pulmonary Disease with COVID-19.
    Gemicioglu B; Uzun H; Borekci S; Karaali R; Kurugoglu S; Atukeren P; Sirolu S; Durmus S; Dirican A; Kuskucu MA; Tabak F
    J Infect Dev Ctries; 2021 Oct; 15(10):1415-1425. PubMed ID: 34780364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.
    Wark PAB; Pathinayake PS; Eapen MS; Sohal SS
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34244320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and 'basal' exacerbation frequency in COPD.
    Cheng DO; Hurst JR
    Thorax; 2021 May; 76(5):432-433. PubMed ID: 33443208
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
    Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asthma and COPD management during the COVID-19 pandemic].
    Daccord C; Touilloux B; Von Garnier C
    Rev Med Suisse; 2020 May; 16(692):933-938. PubMed ID: 32374540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease.
    Peng Y; Wang ZN; Chen SY; Xu AR; Fang ZF; Sun J; Zhou ZQ; Hou XT; Cen LJ; Ma JJ; Zhao JC; Guan WJ; Wang DY; Zhong NS
    Am J Physiol Lung Cell Mol Physiol; 2022 May; 322(5):L712-L721. PubMed ID: 35318858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
    Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of coronavirus disease-2019 on chronic respiratory disease in South Korea: an NHIS COVID-19 database cohort study.
    Oh TK; Song IA
    BMC Pulm Med; 2021 Jan; 21(1):12. PubMed ID: 33407347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
    Arutiunov GP; Tarlovskaia EI; Koziolova NA; Boldina MV; Batiushin MM; Ametov AS; Arutiunov AG; Belevskii AS; Galstian GR; Grigor'eva NI; Dzhunusbekova GA; Esaian AM; Mal'chikova SV; Mit'kovskaia NP; Mkrtumian AM; Orlova IA; Petrova MM; Rebrov AP; Ruzanov DI; Salukhov VV; Sisakian AS; Skibitskii VV; Sugraliev AB; Fomin IV; Khalimov IS; Chesnikova AI; Shaposhnik II; Shestakova MV
    Ter Arkh; 2020 Oct; 92(9):108-124. PubMed ID: 33346439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
    Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
    Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting pulmonary rehabilitation during COVID-19 pandemic: a narrative review.
    Dixit S; Borghi-Silva A; Bairapareddy KC
    Rev Cardiovasc Med; 2021 Jun; 22(2):315-327. PubMed ID: 34258900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect modification by age of the association between obstructive lung diseases, smoking, and COVID-19 severity.
    Moschovis PP; Lu M; Hayden D; Yonker LM; Lombay J; Taveras E; Arauz Boudreau A; Triant VA; Foulkes AS; Bassett I; Hibberd PL; Kinane TB
    BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34740944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Are the Long-term Pulmonary Sequelae of COVID-19 Infection?
    Elicker BM
    Radiology; 2022 Jul; 304(1):193-194. PubMed ID: 35289668
    [No Abstract]   [Full Text] [Related]  

  • 15. More Data on Risks and Outcomes of COVID-19 in Asthma, COPD, and Bronchiectasis.
    Chung KF
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2656-2657. PubMed ID: 33915310
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward Unbiased Evaluation of Postacute Sequelae of SARS-CoV-2 Infection: Challenges and Solutions for the Long Haul Ahead.
    Wisk LE; Nichol G; Elmore JG
    Ann Intern Med; 2022 May; 175(5):740-743. PubMed ID: 35254883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postacute Sequelae of SARS-CoV-2 Infection.
    Batra A; Nath A; Koralnik IJ
    JAMA; 2023 Oct; 330(15):1491-1492. PubMed ID: 37847279
    [No Abstract]   [Full Text] [Related]  

  • 18. Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic.
    Berghaus TM; Karschnia P; Haberl S; Schwaiblmair M
    Respir Med; 2022 Jan; 191():106120. PubMed ID: 32839072
    [No Abstract]   [Full Text] [Related]  

  • 19. Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.
    Avdeev S; Moiseev S; Brovko M; Yavorovskiy A; Umbetova K; Akulkina L; Tsareva N; Merzhoeva Z; Gainitdinova V; Fomin V
    Allergy; 2020 Oct; 75(10):2703-2704. PubMed ID: 32455491
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
    Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
    Front Immunol; 2021; 12():678661. PubMed ID: 34335580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.